# A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

> **NCT06087536** · PHASE2 · RECRUITING · sponsor: **Omnix Medical Ltd** · enrollment: 54 (estimated)

## Conditions studied

- Hospital-acquired Bacterial Pneumonia
- Ventilator-associated Bacterial Pneumonia

## Interventions

- **DRUG:** OMN6
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06087536
- **Lead sponsor:** Omnix Medical Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087536, "A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06087536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*